Literature DB >> 1555161

Neonatal surfactant replacement therapy. Fetus and Newborn Committee, Canadian Paediatric Society.

.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1555161      PMCID： PMC1488529     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.

Authors:  C Bose; A Corbet; G Bose; J Garcia-Prats; L Lombardy; D Wold; D Donlon; W Long
Journal:  J Pediatr       Date:  1990-12       Impact factor: 4.406

2.  Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1.

Authors:  A Corbet; R Bucciarelli; S Goldman; M Mammel; D Wold; W Long
Journal:  J Pediatr       Date:  1991-02       Impact factor: 4.406

3.  Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.

Authors:  W Long; T Thompson; H Sundell; R Schumacher; F Volberg; R Guthrie
Journal:  J Pediatr       Date:  1991-04       Impact factor: 4.406

4.  Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.

Authors:  T A Merritt; M Hallman; C Berry; M Pohjavuori; D K Edwards; J Jaaskelainen; M R Grafe; Y Vaucher; P Wozniak; G Heldt
Journal:  J Pediatr       Date:  1991-04       Impact factor: 4.406

5.  A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation.

Authors:  J W Kendig; R H Notter; C Cox; L J Reubens; J M Davis; W M Maniscalco; R A Sinkin; A Bartoletti; H S Dweck; M J Horgan
Journal:  N Engl J Med       Date:  1991-03-28       Impact factor: 91.245

6.  Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.

Authors:  R F Soll; R E Hoekstra; J J Fangman; A J Corbet; J M Adams; L S James; K Schulze; W Oh; J D Roberts; J P Dorst
Journal:  Pediatrics       Date:  1990-06       Impact factor: 7.124

7.  A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndrome.

Authors:  J D Horbar; R F Soll; H Schachinger; G Kewitz; H T Versmold; W Lindner; G Duc; D Mieth; O Linderkamp; E P Zilow
Journal:  Eur J Pediatr       Date:  1990-03       Impact factor: 3.183

8.  A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.

Authors:  W Long; A Corbet; R Cotton; S Courtney; G McGuiness; D Walter; J Watts; J Smyth; H Bard; V Chernick
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

9.  A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.

Authors:  J D Horbar; R F Soll; J M Sutherland; U Kotagal; A G Philip; D L Kessler; G A Little; W H Edwards; D Vidyasagar; T N Raju
Journal:  N Engl J Med       Date:  1989-04-13       Impact factor: 91.245

10.  Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial.

Authors:  M Hallman; T A Merritt; A L Jarvenpaa; B Boynton; F Mannino; L Gluck; T Moore; D Edwards
Journal:  J Pediatr       Date:  1985-06       Impact factor: 4.406
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.